Interferon regulatory factor 7 (IRF7) is identified as a novel cardiovascular stress inducer in pathologically stressed hearts and involved in the etiology of metabolic disorders, which becoming a new strategy for the treatment of obesity and type 2 diabetes [17,34]. The gene discussed is IRF7; the disease is type 2 diabetes mellitus.